NewGenIvf Group Total Asset vs. Retained Earnings

NIVF Stock   0.39  0.02  4.88%   
Considering NewGenIvf Group's profitability and operating efficiency indicators, NewGenIvf Group Limited may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess NewGenIvf Group's ability to earn profits and add value for shareholders.

NewGenIvf Group Total Assets

34.29 Million

At this time, NewGenIvf Group's EV To Sales is most likely to drop in the upcoming years. The NewGenIvf Group's current Days Of Sales Outstanding is estimated to increase to 75.14, while Sales General And Administrative To Revenue is projected to decrease to 0.18. At this time, NewGenIvf Group's Total Other Income Expense Net is most likely to increase significantly in the upcoming years. The NewGenIvf Group's current Income Quality is estimated to increase to 1.30, while Net Interest Income is projected to decrease to (47.9 K).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.220.3274
Way Down
Pretty Stable
For NewGenIvf Group profitability analysis, we use financial ratios and fundamental drivers that measure the ability of NewGenIvf Group to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well NewGenIvf Group Limited utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between NewGenIvf Group's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of NewGenIvf Group Limited over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NewGenIvf Group. If investors know NewGenIvf will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NewGenIvf Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of NewGenIvf Group is measured differently than its book value, which is the value of NewGenIvf that is recorded on the company's balance sheet. Investors also form their own opinion of NewGenIvf Group's value that differs from its market value or its book value, called intrinsic value, which is NewGenIvf Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NewGenIvf Group's market value can be influenced by many factors that don't directly affect NewGenIvf Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NewGenIvf Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if NewGenIvf Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NewGenIvf Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

NewGenIvf Group Retained Earnings vs. Total Asset Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining NewGenIvf Group's current stock value. Our valuation model uses many indicators to compare NewGenIvf Group value to that of its competitors to determine the firm's financial worth.
NewGenIvf Group Limited is considered to be number one stock in total asset category among its peers. It also is considered to be number one stock in retained earnings category among its peers . At this time, NewGenIvf Group's Total Assets are most likely to increase significantly in the upcoming years. Comparative valuation analysis is a catch-all technique that is used if you cannot value NewGenIvf Group by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

NewGenIvf Retained Earnings vs. Total Asset

Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.

NewGenIvf Group

Total Asset

 = 

Tangible Assets

+

Intangible Assets

 = 
21.32 M
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.

NewGenIvf Group

Retained Earnings

 = 

Beginning RE + Income

-

Dividends

 = 
(5.67 M)
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.

NewGenIvf Retained Earnings Comparison

NewGenIvf Group is currently under evaluation in retained earnings category among its peers.

NewGenIvf Group Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in NewGenIvf Group, profitability is also one of the essential criteria for including it into their portfolios because, without profit, NewGenIvf Group will eventually generate negative long term returns. The profitability progress is the general direction of NewGenIvf Group's change in net profit over the period of time. It can combine multiple indicators of NewGenIvf Group, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-7.3 K-6.9 K
Net Interest Income-45.7 K-47.9 K
Interest Income 518.00  543.90 
Operating Income-2.5 M-2.4 M
Net Income From Continuing Ops108.4 K113.8 K
Income Before Tax-690.9 K-656.3 K
Total Other Income Expense Net1.8 M1.9 M
Net Loss-690.9 K-656.3 K
Income Tax Expense-229.7 K-218.2 K
Net Loss(0.13)(0.12)
Income Quality 1.24  1.30 
Net Income Per E B T 0.82  0.87 

NewGenIvf Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on NewGenIvf Group. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of NewGenIvf Group position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the NewGenIvf Group's important profitability drivers and their relationship over time.

Use NewGenIvf Group in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NewGenIvf Group position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NewGenIvf Group will appreciate offsetting losses from the drop in the long position's value.

NewGenIvf Group Pair Trading

NewGenIvf Group Limited Pair Trading Analysis

The ability to find closely correlated positions to NewGenIvf Group could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NewGenIvf Group when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NewGenIvf Group - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NewGenIvf Group Limited to buy it.
The correlation of NewGenIvf Group is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NewGenIvf Group moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NewGenIvf Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NewGenIvf Group can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your NewGenIvf Group position

In addition to having NewGenIvf Group in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Single Stock ETFs Thematic Idea Now

Single Stock ETFs
Single Stock ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Single Stock ETFs theme has 100 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Single Stock ETFs Theme or any other thematic opportunities.
View All  Next Launch
When determining whether NewGenIvf Group is a strong investment it is important to analyze NewGenIvf Group's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact NewGenIvf Group's future performance. For an informed investment choice regarding NewGenIvf Stock, refer to the following important reports:
Check out Correlation Analysis.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
To fully project NewGenIvf Group's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of NewGenIvf Group at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include NewGenIvf Group's income statement, its balance sheet, and the statement of cash flows.
Potential NewGenIvf Group investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although NewGenIvf Group investors may work on each financial statement separately, they are all related. The changes in NewGenIvf Group's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on NewGenIvf Group's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.